ketanserin has been researched along with Disorder, Borderline Personality in 2 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soloff, PH | 2 |
| Chiappetta, L | 1 |
| Mason, NS | 1 |
| Becker, C | 1 |
| Price, JC | 2 |
| Meltzer, CC | 1 |
| Fabio, A | 1 |
| Frank, GK | 1 |
| Kaye, WH | 1 |
2 other studies available for ketanserin and Disorder, Borderline Personality
| Article | Year |
|---|---|
Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder.
Topics: Adult; Aggression; Borderline Personality Disorder; Contrast Media; Depression; Female; Fluorodeoxyg | 2014 |
5HT2A receptor binding is increased in borderline personality disorder.
Topics: Adult; Aggression; Borderline Personality Disorder; Brain; Child; Child Abuse; Depression; Female; F | 2007 |